Nurse Practitioner, Family · Jackson, MS
NPI
1215422480
Since 2018
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
969 Lakeland Dr
Jackson, MS, 39216
Phone (601) 200-2280
Groups this clinician bills Medicare through
Medicare paid, 2024
$49K
2,724 services
Medicare patients, 2024
300
Average age 76
Drug cost, 2024
$1.8M
2,527 prescriptions
Company payments, 2025
$1,298
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kayla M Smith was code 93793 (care management/coordination), 1,216 times for 82 patients. In total Kayla M Smith billed 2,724 services in 13 codes, and Medicare paid $49K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-10-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 93793 Care Management/Coordination | Office | 1,216 | 82 | $6.31 | $7,670 |
| 36415 Venipuncture Blood Collection | Office | 357 | 160 | $8.58 | $3,064 |
| 99214 Office E&M - Established | Office | 264 | 146 | $71.49 | $19K |
| 99213 Office E&M - Established | Office | 250 | 156 | $52.62 | $13K |
| 85610 Clinical Chemistry | Office | 213 | 56 | $4.20 | $895 |
| J1940 Injection, furosemide, up to 20 mg | Office | 210 | 44 | $0.36 | $75.77 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 104 | 82 | $9.66 | $1,005 |
| 96374 Injection Administration | Office | 67 | 44 | $19.90 | $1,333 |
| 99204 Office E&M - New | Office | 26 | 26 | $95.73 | $2,489 |
By year: 2022 $18K for 479 services; 2023 $39K for 1,232 services; 2024 $49K for 2,724 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 357 | 160 | $8.58 | $3,064 |
| 85610 Clinical Chemistry | 213 | 56 | $4.20 | $895 |
Medicare prescription drug claims, 2024
In 2024, the drug Kayla M Smith prescribed most often to Medicare patients was Warfarin Sodium, with 307 prescriptions and refills. In total Kayla M Smith wrote 2,527 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Warfarin Sodium Generic | 307 | 795 | 97 | $3,064 |
| Furosemide Generic | 272 | 732 | 110 | $1,568 |
| Farxiga Dapagliflozin Propanediol | 245 | 505 | 65 | $265K |
| Entresto Sacubitril/Valsartan | 242 | 470 | 78 | $304K |
| Spironolactone Generic | 223 | 580 | 96 | $1,670 |
| Jardiance Empagliflozin | 186 | 380 | 62 | $214K |
| Carvedilol Generic | 173 | 448 | 61 | $1,458 |
| Metoprolol Succinate Generic | 111 | 300 | 47 | $1,782 |
| Potassium Chloride Generic | 106 | 213 | 51 | $1,179 |
| Torsemide Generic | 96 | 228 | 40 | $3,291 |
| Verquvo Vericiguat | 95 | 177 | 25 | $114K |
| Hydralazine Hcl Generic | 62 | 178 | 25 | $1,580 |
| Metolazone Generic | 55 | 64 | 28 | $137 |
| Nifedipine Er Nifedipine | 30 | 90 | 13 | $1,048 |
| Losartan Potassium Generic | 24 | 50 | Under 11 | $70.41 |
Brand drugs: 942 claims; generic drugs: 1,585 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kayla M Smith $1,298 ($1,298 in general payments such as food, travel and fees) from 9 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $235.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 6 | $235 |
| Alnylam Pharmaceuticals Inc. ALNY | 9 | $223 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 8 | $206 |
| Merck Sharp & Dohme LLC MRK | 6 | $169 |
| Pfizer Inc. PFE | 10 | $159 |
| UCB, Inc. UCB.BR | 1 | $129 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $110 |
| BridgeBio Pharma, Inc. BBIO | 2 | $35.92 |
| Scpharmaceuticals Inc. SCPH | 2 | $31.96 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.